AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30606469 — intervention group
Group type: COMPARATOR
Intervention: Standard care protocol
Number of subjects: 180
Study 28077732 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein breakfast (19-20 g protein)
Number of subjects: 41
Study 28077732 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fiber breakfast (10-11 g fiber)
Number of subjects: 41
Study 28077732 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined High-Protein and High-Fiber breakfast (19-21 g protein, 10-12 g fiber)
Number of subjects: 41
Study 28077732 — intervention group
Group type: COMPARATOR
Intervention: Usual breakfast (control)
Number of subjects: 41
Study 26298524 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary educational program with instructions to follow a conventional energy restricted diet
Number of subjects: 60
Study 26298524 — intervention group
Group type: COMPARATOR
Intervention: Control group following the same healthy diet without calorie restriction
Number of subjects: 60
Study 24036466 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS) applied for 20 minutes to the primary motor cortex (M1)
Number of subjects: 0
Study 24036466 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (stDCS)
Number of subjects: 0
Study 21233605 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 175
Study 21233605 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Thal fundoplication
Number of subjects: 175
Study 21233605 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 175
Study 20054083 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Ventilator computer simulation (SIM-1st)
Number of subjects: 109
Study 20054083 — intervention group
Group type: COMPARATOR
Intervention: Live-animal mechanical ventilation laboratory (LIVE-1st)
Number of subjects: 109
Study 17717919 — intervention group
Group type: EXPERIMENTAL
Intervention: Qifang Weitong Powder combined with omeprazole (QWP‐Op)
Number of subjects: 60
Study 17717919 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 60
Study 16877627 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental drug outside of a study
Number of subjects: 420
Study 16877627 — intervention group
Group type: EXPERIMENTAL
Intervention: New drug as part of a study
Number of subjects: 420
Study 16877627 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trial (RCT) for a new drug
Number of subjects: 420
Study 16877627 — intervention group
Group type: EXPERIMENTAL
Intervention: Study of thoracotomy
Number of subjects: 420
Study 16877627 — intervention group
Group type: EXPERIMENTAL
Intervention: Study requiring placement of a femoral catheter
Number of subjects: 420
Study 12640509 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg/day
Number of subjects: 41
Study 12640509 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg/day
Number of subjects: 41
Study 10852357 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month treatment programs
Number of subjects: 0
Study 10852357 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer residential treatment program
Number of subjects: 0
Study 10852357 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of prior arrests
Number of subjects: 0
Study 8843935 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice bulletin board
Number of subjects: 53
Study 1640226 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced therapy regime (increased treatment and behavioral methods)
Number of subjects: 132
Study 1640226 — intervention group
Group type: COMPARATOR
Intervention: Orthodox physiotherapy
Number of subjects: 132
Study 6384911 — intervention group
Group type: EXPERIMENTAL
Intervention: A.C.T. (Asthma Care Training) for Kids - 5 sessions of 1 hour each
Number of subjects: 76
Study 6384911 — intervention group
Group type: COMPARATOR
Intervention: Control group - 4 1/2 hours of lecture presentations on asthma and its management
Number of subjects: 76
Study 6384911 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 76
Study 31897315 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine spray (1 puff, 1.5 mg/kg)
Number of subjects: 90
Study 31897315 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin spray (1 puff, 400 μg)
Number of subjects: 90
Study 31897315 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study 28824850 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad-based cognitive training (CT)
Number of subjects: 74
Study 28824850 — intervention group
Group type: COMPARATOR
Intervention: Desktop-based cognitive training (CT)
Number of subjects: 74
Study 28824850 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 74
Study 26656984 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice level intervention over 6 months including small group training, feedback on audited performance, practice facilitation visits, and provision of patient education and referral information.
Number of subjects: 122
Study 26656984 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 122
Study 26656984 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice level intervention.
Number of subjects: 122
Study 24217426 — intervention group
Group type: EXPERIMENTAL
Intervention: structured exercise
Number of subjects: 221
Study 24217426 — intervention group
Group type: EXPERIMENTAL
Intervention: lifestyle exercise
Number of subjects: 221
Study 24217426 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise
Number of subjects: 221
Study 21457426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg)
Number of subjects: 5238
Study 21457426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5238
Study 18708008 — intervention group
Group type: EXPERIMENTAL
Intervention: Red crowding bars
Number of subjects: 101
Study 18708008 — intervention group
Group type: EXPERIMENTAL
Intervention: Green crowding bars
Number of subjects: 101
Study 18708008 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow crowding bars
Number of subjects: 101
Study 18708008 — intervention group
Group type: COMPARATOR
Intervention: Black crowding bars
Number of subjects: 101
Study 18708008 — intervention group
Group type: EXPERIMENTAL
Intervention: Red crowding bars in second phase
Number of subjects: 101
Study 17083289 — intervention group
Group type: EXPERIMENTAL
Intervention: Single direction change in color and motion stimulus
Number of subjects: 0
Study 15389355 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11423812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential presentation format
Number of subjects: 10
Study 11423812 — intervention group
Group type: EXPERIMENTAL
Intervention: Grouped presentation format
Number of subjects: 10
Study 11423812 — intervention group
Group type: COMPARATOR
Intervention: Control specimen (before SF administration)
Number of subjects: 10
Study 9245846 — intervention group
Group type: EXPERIMENTAL
Intervention: Information booklet and verbal counselling
Number of subjects: 200
Study 9245846 — intervention group
Group type: COMPARATOR
Intervention: Verbal counselling only
Number of subjects: 200
Study 8490197 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF (cyclophosphamide, methotrexate and 5‐fluorouracil, every 3 weeks)
Number of subjects: 38
Study 8490197 — intervention group
Group type: COMPARATOR
Intervention: CXF (cyclophosphamide, mitoxantrone and 5‐fluorouracil, every 3 weeks)
Number of subjects: 38
Study 3106448 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral gold therapy
Number of subjects: 8
Study 30761786 — intervention group
Group type: EXPERIMENTAL
Intervention: Canephron N (2 tablets 3 times daily for 30 days)
Number of subjects: 160
Study 30761786 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin (0.5 g twice daily for 3 days)
Number of subjects: 160
Study 27274223 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-regulated volume control (PRVC) ventilation
Number of subjects: 39
Study 27274223 — intervention group
Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation - volume control
Number of subjects: 39
Study 25382328 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose atorvastatin 80 mg/d (HD group)
Number of subjects: 165
Study 25382328 — intervention group
Group type: COMPARATOR
Intervention: Normal dose atorvastatin 20 mg/d (ND group)
Number of subjects: 165
Study 25382328 — intervention group
Group type: COMPARATOR
Intervention: Loading dose atorvastatin 80 mg followed by 20 mg/d (LD group)
Number of subjects: 165
Study 23519529 — intervention group
Group type: COMPARATOR
Intervention: Group 1: 10 mg of lutein, 1 mg of zeaxanthin, 100 mg of docosahexaenoic acid, and 30 mg of eicosapentaenoic acid daily
Number of subjects: 172
Study 23519529 — intervention group
Group type: COMPARATOR
Intervention: Group 2: Double the dose of Group 1
Number of subjects: 172
Study 23519529 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 172
Study 20943956 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Zn/d as Zn sulfate
Number of subjects: 58
Study 20943956 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg Zn/d as Zn sulfate
Number of subjects: 58
Study 20943956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 19097473 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical rest condition before and after the execution of exercises (a series of mandibular movements)
Number of subjects: 8
Study 16617390 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc‐DMSA renal scintigraphy in children with UTI and VUR
Number of subjects: 343
Study 16617390 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc‐DMSA renal scintigraphy in children with UTI without VUR
Number of subjects: 343
Study 16617390 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc‐DMSA renal scintigraphy in children with VUR grades I, II, III, IV and V
Number of subjects: 343
Study 12895359 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid gas‐permeable lens (RGP)
Number of subjects: 23
Study 12895359 — intervention group
Group type: COMPARATOR
Intervention: Soft contact lens (SCL)
Number of subjects: 23
Study 12895359 — intervention group
Group type: COMPARATOR
Intervention: Spectacles with resin lens material (SP)
Number of subjects: 23
Study 10935308 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic measurements of fetal growth parameters (biparietal diameter, head circumference, abdominal diameter, abdominal circumference, femur length)
Number of subjects: 10043
Study 8994098 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial meningitis
Number of subjects: 23
Study 8994098 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral meningitis
Number of subjects: 23
Study 8994098 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil granulocytes
Number of subjects: 23
Study 8994098 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocytes and monocytes/macrophages
Number of subjects: 23
Study 8994098 — intervention group
Group type: EXPERIMENTAL
Intervention: TGF beta 1
Number of subjects: 23
Study 1618564 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin traction
Number of subjects: 80
Study 1618564 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal traction
Number of subjects: 80
Study 1618564 — intervention group
Group type: COMPARATOR
Intervention: No traction (control)
Number of subjects: 80
Study 6322489 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable polyglycolic acid sutures (Dexon)
Number of subjects: 58
Study 6322489 — intervention group
Group type: COMPARATOR
Intervention: Non-absorbable sutures (Dacron)
Number of subjects: 58
Study 30926065 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 85
Study 30926065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 30383205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal lampalizumab treatment
Number of subjects: 77
Study 29927182 — intervention group
Group type: EXPERIMENTAL
Intervention: MDI with DIY spacer
Number of subjects: 40
Study 29927182 — intervention group
Group type: COMPARATOR
Intervention: Nebulizer
Number of subjects: 40
Study 25496727 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina supplementation combined with local diet
Number of subjects: 169
Study 25496727 — intervention group
Group type: COMPARATOR
Intervention: Local diet only
Number of subjects: 169
Study 23328702 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 µg/day folic acid
Number of subjects: 29
Study 23328702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 20040705 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care intervention
Number of subjects: 58
Study 20040705 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 58
Study 18538965 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-held health records
Number of subjects: 0
Study 18538965 — intervention group
Group type: COMPARATOR
Intervention: Usual follow-up
Number of subjects: 0
Study 16344059 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy
Number of subjects: 2324
Study 16344059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2324
Study 14696818 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway 2 (new pathway incorporating semi‐quantitative cTnT measurement)
Number of subjects: 200
Study 14696818 — intervention group
Group type: COMPARATOR
Intervention: Pathway 1 (existing chest pain care pathway)
Number of subjects: 200
Study 10934892 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms BID)
Number of subjects: 634
Study 8941107 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol at 50 to 100 mg/d
Number of subjects: 0
Study 8941107 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol at 125 to 150 mg/d
Number of subjects: 0
Study 8941107 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0
Study 8941107 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 1399423 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized method of optic nerve head pallor measurement
Number of subjects: 30
Study 1399423 — intervention group
Group type: COMPARATOR
Intervention: Manual boundary tracking
Number of subjects: 30
Study 1399423 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized method
Number of subjects: 30
Study 1399423 — intervention group
Group type: COMPARATOR
Intervention: Manual method
Number of subjects: 30
Study 4002801 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg muzolimine
Number of subjects: 18
Study 4002801 — intervention group
Group type: COMPARATOR
Intervention: 40 mg furosemide
Number of subjects: 18
Study 31633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert identification of interictal epileptiform discharges (IEDs) in EEGs
Number of subjects: 1051
Study 31633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert identification of whether an EEG contained any IEDs
Number of subjects: 1051
Study 31633742 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical model based on waveform morphological features
Number of subjects: 1051
Study 30320566 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC (Remote Ischemic Preconditioning)
Number of subjects: 0
Study 30320566 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC+ (Remote Ischemic Preconditioning combined with electronic muscle stimulation)
Number of subjects: 0
Study 30320566 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30320566 — intervention group
Group type: EXPERIMENTAL
Intervention: RIPC
Number of subjects: 0
Study 27267854 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate + prednisone (1,000 mg/d + 5 mg/d)
Number of subjects: 293
Study 27267854 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate + exemestane (1,000 mg/d + 25 mg/d)
Number of subjects: 293
Study 27267854 — intervention group
Group type: COMPARATOR
Intervention: Exemestane
Number of subjects: 293
Study 24796463 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab administered concurrently with anthracycline-containing adjuvant regimen
Number of subjects: 109
Study 24796463 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab administered sequentially with anthracycline
Number of subjects: 109
Study 22748457 — intervention group
Group type: EXPERIMENTAL
Intervention: Heating humidifier with heating wire in pipeline
Number of subjects: 120
Study 22748457 — intervention group
Group type: COMPARATOR
Intervention: Routine airway management (control group)
Number of subjects: 120
Study 20544134 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping at three minutes
Number of subjects: 255
Study 20544134 — intervention group
Group type: COMPARATOR
Intervention: Early umbilical cord clamping within the first 15 seconds
Number of subjects: 255
Study 20544134 — intervention group
Group type: COMPARATOR
Intervention: Delayed umbilical cord clamping at one minute
Number of subjects: 255
Study 20544134 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (early, one minute, three minutes)
Number of subjects: 255
Study 18771049 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg twice daily of Phase III formulation
Number of subjects: 92
Study 18771049 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg twice daily of Phase III formulation
Number of subjects: 92
Study 18771049 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg twice daily of Phase II formulation
Number of subjects: 92
Study 15956235 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 17
Study 15956235 — intervention group
Group type: EXPERIMENTAL
Intervention: Valdecoxib
Number of subjects: 17
Study 15956235 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 17
Study 15956235 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib
Number of subjects: 17
Study 15956235 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 17
Study 15552851 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinfusion of drained mediastinal blood
Number of subjects: 260
Study 15552851 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reinfusion)
Number of subjects: 260
Study 12176916 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cyclosporin A (CsA)
Number of subjects: 73
Study 12176916 — intervention group
Group type: COMPARATOR
Intervention: Cytarabine and infusional daunorubicin without CsA (Control)
Number of subjects: 73
Study 10207508 — intervention group
Group type: EXPERIMENTAL
Intervention: GH administration (i.v. GH bolus)
Number of subjects: 36
Study 10207508 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin infusion with GH administration
Number of subjects: 36
Study 10207508 — intervention group
Group type: EXPERIMENTAL
Intervention: GH substitution during fasting in GH-deficient patients
Number of subjects: 36
Study 10207508 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term GH treatment during hypocaloric diet in obesity
Number of subjects: 36
Study 10207508 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin induced hypoglycemia in GH-deficient patients
Number of subjects: 36
Study 7598298 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly regimen of sulfadiazine (500 mg four times per day) plus pyrimethamine (25 mg) plus folinic acid (15 mg)
Number of subjects: 105
Study 7598298 — intervention group
Group type: COMPARATOR
Intervention: Daily regimen of sulfadiazine (500 mg four times per day) plus pyrimethamine (25 mg) plus folinic acid (15 mg)
Number of subjects: 105
Study 7598298 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly regimen
Number of subjects: 105
Study 7598298 — intervention group
Group type: COMPARATOR
Intervention: Daily regimen
Number of subjects: 105
Study 7598298 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 105
Study 2184706 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TAC (0.5% tetracaine, 1:2,000 adrenalin, 11.8% cocaine)
Number of subjects: 151
Study 2184706 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal lidocaine
Number of subjects: 151
Study 2184706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 2184706 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TAC
Number of subjects: 151
Study 7468984 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulation anaesthesia (ESA)
Number of subjects: 26
Study 7468984 — intervention group
Group type: COMPARATOR
Intervention: Neurolept anaesthesia (NLA)
Number of subjects: 26
Study 6686849 — intervention group
Group type: EXPERIMENTAL
Intervention: CAE + cisplatinum (CAE-P)
Number of subjects: 68
Study 6686849 — intervention group
Group type: COMPARATOR
Intervention: CAE (without cisplatinum)
Number of subjects: 68
Study 30707409 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease patients
Number of subjects: 60
Study 30231866 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine 25 or 50 micrograms daily
Number of subjects: 291
Study 30231866 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 291
Study 27525699 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (SXT)
Number of subjects: 97
Study 27525699 — intervention group
Group type: COMPARATOR
Intervention: Second-generation cephalosporins (2GC)
Number of subjects: 97
Study 24249841 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 48
Study 24249841 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Resistance Training with Pulsed Electromagnetic Fields (RTPEMF)
Number of subjects: 48
Study 24249841 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 24249841 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Fields (PEMF)
Number of subjects: 48
Study 22727992 — intervention group
Group type: EXPERIMENTAL
Intervention: Bax expression in lens epithelial cells (LECs)
Number of subjects: 60
Study 22727992 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl-2 expression in lens epithelial cells (LECs)
Number of subjects: 60